These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9052824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR, Shebert R, Gregorios JB.
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract] [Full Text] [Related]

  • 3. [Myopathy and zidovudine].
    Mateo O, Gato A, Ballesteros P, Benito L, Pontes MJ, Esquinas G.
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):474-6. PubMed ID: 1489776
    [Abstract] [Full Text] [Related]

  • 4. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB, Drucker RP, McKinney RE, Wilfert CM.
    J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract] [Full Text] [Related]

  • 5. Myalgias in human immunodeficiency virus-infected patients.
    Buskila D, Langevitz P.
    Am J Med; 1989 Apr; 86(4):510-1. PubMed ID: 2929650
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HIV or zidovudine myopathy?
    Kieburtz K.
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy.
    Jay C, Ropka M, Dalakas MC.
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):630-1. PubMed ID: 8176648
    [No Abstract] [Full Text] [Related]

  • 13. Necrotising myopathy and zidovudine.
    Lancet; 1988 May 07; 1(8593):1050-1. PubMed ID: 2896888
    [No Abstract] [Full Text] [Related]

  • 14. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH, Zorn I, Zwart R, Portegies P, Bolhuis PA.
    Muscle Nerve; 1992 Jun 07; 15(6):706-10. PubMed ID: 1324428
    [Abstract] [Full Text] [Related]

  • 15. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe DE.
    Neurology; 1993 May 07; 43(5):971-6. PubMed ID: 8492955
    [Abstract] [Full Text] [Related]

  • 16. Criteria for use of zidovudine in adult and pediatric inpatients and outpatients.
    Goodwin SD, Shipp KW.
    Clin Pharm; 1992 Jan 07; 11(1):63-8. PubMed ID: 1730181
    [No Abstract] [Full Text] [Related]

  • 17. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM, Bertram M, Schnabel R, Pfaff U.
    Acta Neuropathol; 1992 Jan 07; 85(1):39-47. PubMed ID: 1285495
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.